Dana Hilt Phones & Addresses
-
Waltham, MA
Business Records
Name / Title
Company / Classification
Phones & Addresses
Senior Vice President Clinical Development/chief Medical Officer
Envivo Pharmaceuticals
Pharmaceutical Products Wholesale & Manufacturers · Pharmacy & Pharmaceutical Consultants
Pharmaceutical Products Wholesale & Manufacturers · Pharmacy & Pharmaceutical Consultants
343 Arsenal St, Watertown, MA 02472
480 Arsenal St BLDG 1, Watertown, MA 02472
(617) 393-0302, (617) 225-4250
480 Arsenal St BLDG 1, Watertown, MA 02472
(617) 393-0302, (617) 225-4250
Publications
Us Patents
Treatment Of Cognitive Disorders With Certain Alpha-7 Nicotinic Acid Receptors In Combination With Acetylcholinesterase Inhibitors
View pageUS Patent:
20110124631, May 26, 2011
Filed:
Dec 27, 2010
Appl. No.:
12/979139
Inventors:
Gerhard Koenig - Newton MA, US
Dana Hilt - Waltham MA, US
Dana Hilt - Waltham MA, US
International Classification:
A61K 31/439
A61K 31/473
A61K 31/55
A61P 25/00
A61P 25/28
A61K 31/473
A61K 31/55
A61P 25/00
A61P 25/28
US Classification:
514215, 514305, 514297
Abstract:
A method for improving cognition comprising administering to a patient (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide or a pharmaceutically acceptable salt thereof and an acetylcholinesterase inhibitor is described together with related compositions.
Treatment Of Cognitive Disorders With Certain Alpha-7 Nicotinic Acid Receptor Agonists In Combination With Acetylcholinesterase Inhibitors
View pageUS Patent:
20130225560, Aug 29, 2013
Filed:
Jul 25, 2011
Appl. No.:
13/812260
Inventors:
Gerhard Koenig - Newton MA, US
Dana Hilt - Waltham MA, US
Dana Hilt - Waltham MA, US
Assignee:
ENVIVO PHARMACEUTICALS, INC. - Watertown MA
International Classification:
A61K 31/439
A61K 31/501
A61K 31/55
A61K 31/473
A61K 31/325
A61K 31/444
A61K 31/445
A61K 31/501
A61K 31/55
A61K 31/473
A61K 31/325
A61K 31/444
A61K 31/445
US Classification:
514215, 514305, 51425204, 514297
Abstract:
A method for improving cognition comprising administering to a patient certain alpha-7 receptor agonists and an acetylcholinesterase inhibitor is described together with related compositions.
Treatment Of Cognitive Disorders With Certain Alpha-7 Nicotinic Acid Receptors In Combination With Acetylcholinesterase Inhibitors
View pageUS Patent:
20150126546, May 7, 2015
Filed:
Jun 17, 2014
Appl. No.:
14/307139
Inventors:
- Watertown MA, US
Dana Hilt - Waltham MA, US
Dana Hilt - Waltham MA, US
International Classification:
A61K 31/445
A61K 45/06
A61K 31/439
A61K 45/06
A61K 31/439
US Classification:
514305
Abstract:
A method for improving cognition comprising administering to a patient (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide or a pharmaceutically acceptable salt thereof and an acetylcholinesterase inhibitor is described together with related compositions.